- Home
- ANIX vs EMCG Comparison
ANIX vs EMCG Comparison
Compare ANIX & EMCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- EMCG
- Stock Information
- Founded
- ANIX 1982
- EMCG 2021
- Country
- ANIX United States
- EMCG United States
- Employees
- ANIX N/A
- EMCG N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- EMCG
- Sector
- ANIX Health Care
- EMCG
- Exchange
- ANIX Nasdaq
- EMCG NYSE
- Market Cap
- ANIX 101.4M
- EMCG 83.7M
- IPO Year
- ANIX 1987
- EMCG 2022
- Fundamental
- Price
- ANIX $3.08
- EMCG $11.55
- Analyst Decision
- ANIX Strong Buy
- EMCG
- Analyst Count
- ANIX 2
- EMCG 0
- Target Price
- ANIX $8.50
- EMCG N/A
- AVG Volume (30 Days)
- ANIX 42.0K
- EMCG 2.3K
- Earning Date
- ANIX 10-29-2024
- EMCG 01-01-0001
- Dividend Yield
- ANIX N/A
- EMCG N/A
- EPS Growth
- ANIX N/A
- EMCG 186.72
- EPS
- ANIX N/A
- EMCG 0.24
- Revenue
- ANIX N/A
- EMCG N/A
- Revenue This Year
- ANIX N/A
- EMCG N/A
- Revenue Next Year
- ANIX N/A
- EMCG N/A
- P/E Ratio
- ANIX N/A
- EMCG $47.89
- Revenue Growth
- ANIX N/A
- EMCG N/A
- 52 Week Low
- ANIX $2.15
- EMCG $10.84
- 52 Week High
- ANIX $5.13
- EMCG $13.39
- Technical
- Relative Strength Index (RSI)
- ANIX 41.08
- EMCG 63.69
- Support Level
- ANIX $2.95
- EMCG $11.47
- Resistance Level
- ANIX $3.11
- EMCG $11.57
- Average True Range (ATR)
- ANIX 0.12
- EMCG 0.02
- MACD
- ANIX -0.01
- EMCG 0.00
- Stochastic Oscillator
- ANIX 19.35
- EMCG 80.00
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About EMCG EMBRACE CHANGE ACQUISITION CORP
Embrace Change Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.